OOIR: Observatory of International Research

Papers

(The median citation count of Heart Failure Reviews is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Severe low-gradient aortic stenosis: impact of inadequate left ventricular responses to high afterload on diagnosis and therapeutic decision-making	45
Imaging techniques for the assessment of adverse cardiac remodeling in metabolic syndrome	45
Validation of the MEDIA echo score for the prognosis of heart failure with preserved ejection fraction	35
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis	34
Right ventricular failure: a comorbidity or a clinical emergency?	32
Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction	27
The cardiosplenic axis: the prognostic role of the spleen in heart failure	27
The role of TAVR in patients with heart failure: do we have the responses to all questions?	26
Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition	24
Correction to: Is it time to revisit ICD indications?	24
Cardiovascular magnetic resonance for suspected cardiac amyloidosis: where are we now?	23
MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers	20
Cardiac 31P MR spectroscopy: development of the past five decades and future vision—will it be of diagnostic use in clinics?	20
Speckle tracking echocardiography in heart failure development and progression in patients with apneas	19
Follistatin-like 1 and its paralogs in heart development and cardiovascular disease	18
Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging	18
State-of-the-art review on management of end-stage heart failure in amyloidosis: transplant and beyond	17
Optimal effectiveness of heart failure management — an umbrella review of meta-analyses examining the effectiveness of interventions to reduce (re)hospitalizations in heart failure	15
Letter to the editor to update the article “Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials”	15
Left ventricular assist device in cardiac amyloidosis: friend or foe?	14
ST-elevation myocardial infarction among cardiac amyloidosis patients; a national readmission database study	14
Targeting mitochondrial dysfunction with elamipretide	13
Predictors of fatal arrhythmic events in patients with non-compaction cardiomyopathy: a systematic review	12
Letter to the Editor	12
Experimental heart failure models in small animals	11

Sudden cardiac death in cardiomyopathies: acting upon “acceptable” risk in the personalized medicine era	10
Myocarditis following COVID-19 vaccination in adolescents and adults: a cumulative experience of 2021	9
Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy	8
New onset nonischemic cardiomyopathy post liver transplantation	7
The role of cardiac magnetic resonance in identifying appropriate candidates for cardiac resynchronization therapy — a systematic review of the literature	7
Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure	6
Soluble ST2: a valuable prognostic marker in heart failure	6
Stepwise approach for diagnosis and management of Takotsubo syndrome with cardiac imaging tools	6
Large animal models of heart failure with preserved ejection fraction	6
Cardiovascular positron emission tomography: established and emerging role in cardiovascular diseases	6